.Attribute Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint asks for inclusion of individuals along with MASLD and measurement of liver results in cardio-- kidney-- metabolic trials, when records recommend mechanistically tenable advantages as well as professional safety and security-- and describes factors for test concept and also regulatory approval.